HRT Financial’s Pliant Therapeutics PLRX Stock Holding History

HRT Financial’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11,196	Closed	-$14K	–	5093
2026 Q1	$14K	Sell	11,196 -21,009	-65%	-$26.5K	﹤0.01%	3606
2025 Q4	$39K	Buy	+32,205	New	+$48.4K	﹤0.01%	2908
2025 Q3	–	Sell	-32,475	Closed	-$37K	–	3478
2025 Q2	$37K	Buy	+32,475	New	+$45.9K	﹤0.01%	2343
2024 Q1	–	Sell	-28,430	Closed	-$514K	–	2909
2023 Q4	$514K	Buy	+28,430	New	+$432K	﹤0.01%	1347
2023 Q2	–	Sell	-165,512	Closed	-$4.4M	–	3085
2023 Q1	$4.4M	Buy	+165,512	New	+$4.71M	0.05%	284
2022 Q4	–	Sell	-11,339	Closed	-$236K	–	2984
2022 Q3	$236K	Buy	+11,339	New	+$217K	﹤0.01%	2144
2022 Q1	–	Sell	-39,298	Closed	-$530K	–	3686
2021 Q4	$530K	Buy	+39,298	New	+$625K	﹤0.01%	1707

Other funds holding PLRX

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

HRT Financial's PLRX Position: Q2 2026 in Review

HRT Financial sold out of Pliant Therapeutics (PLRX) in Q2 2026, closing a stake of 11,196 shares — an estimated $14K sold.

HRT Financial first reported a position in PLRX in Q4 2021 and held it in 7 quarters. The position peaked at $4.4M in Q1 2023. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

HRT Financial reported no remaining Pliant Therapeutics position as of Q2 2026 after selling out during the quarter.
HRT Financial sold 11,196 Pliant Therapeutics shares in Q2 2026, an estimated $14K.
HRT Financial first reported a position in Pliant Therapeutics in Q4 2021 and held it in 7 quarters.
HRT Financial's Pliant Therapeutics position peaked at $4.4M in Q1 2023.
86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.